|
GEN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.38769999830291E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.15319999999453E-07 |
| Normal-vs-Stage2 |
4.28999999968482E-07 |
| Normal-vs-Stage3 |
3.92889998312995E-09 |
| Normal-vs-Stage4 |
4.97659999987299E-07 |
| Stage1-vs-Stage2 |
4.675000E-01 |
| Stage1-vs-Stage3 |
2.440400E-02 |
| Stage1-vs-Stage4 |
1.687610E-01 |
| Stage2-vs-Stage3 |
3.731000E-01 |
| Stage2-vs-Stage4 |
5.004800E-01 |
| Stage3-vs-Stage4 |
9.851000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.6380000052213E-08 |
| Normal-vs-AfricanAmerican |
1.62119000000072E-05 |
| Normal-vs-Asian |
4.63739999956303E-07 |
| Caucasian-vs-AfricanAmerican |
7.059400E-01 |
| Caucasian-vs-Asian |
8.467200E-01 |
| AfricanAmerican-vs-Asian |
7.932600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85250000006576E-07 |
| Normal-vs-Female |
3.03530000023144E-08 |
| Male-vs-Female |
7.191000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64359999949215E-07 |
| Normal-vs-Age(41-60Yrs) |
9.25389997963322E-09 |
| Normal-vs-Age(61-80Yrs) |
1.875699995324E-08 |
| Normal-vs-Age(81-100Yrs) |
5.824200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.064250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.460000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.775400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.589200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.222800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.481800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.363700E-03 |
| Classical-VS-Follicular |
7.391000E-01 |
| Classical-VS-Other |
9.563600E-01 |
| Classical-VS-Normal |
2.88790000024797E-07 |
| Tall-VS-Follicular |
2.204300E-02 |
| Tall-VS-Other |
3.932600E-01 |
| Tall-VS-Normal |
7.73940023179875E-10 |
| Follicular-VS-Other |
9.570200E-01 |
| Follicular-VS-Normal |
4.72049999977742E-07 |
| Other-VS-Normal |
3.686000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09849999985201E-07 |
| Normal-vs-N1 |
7.28700000007798E-07 |
| N0-vs-N1 |
7.219600E-01 |
|
|
